Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
6.38
+0.77 (13.73%)
At close: Aug 13, 2025, 4:00 PM
6.50
+0.12 (1.88%)
After-hours: Aug 13, 2025, 7:28 PM EDT

Passage Bio Statistics

Total Valuation

Passage Bio has a market cap or net worth of $19.91 million. The enterprise value is -$14.49 million.

Market Cap 19.91M
Enterprise Value -14.49M

Important Dates

The last earnings date was Tuesday, August 12, 2025, before market open.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

Passage Bio has 3.12 million shares outstanding. The number of shares has increased by 7.82% in one year.

Current Share Class 3.12M
Shares Outstanding 3.12M
Shares Change (YoY) +7.82%
Shares Change (QoQ) +2.04%
Owned by Insiders (%) 0.21%
Owned by Institutions (%) 46.16%
Float 2.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.46
P/TBV Ratio 0.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.65.

Current Ratio 3.05
Quick Ratio 2.91
Debt / Equity 0.65
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -88.27% and return on invested capital (ROIC) is -37.79%.

Return on Equity (ROE) -88.27%
Return on Assets (ROA) -33.20%
Return on Invested Capital (ROIC) -37.79%
Return on Capital Employed (ROCE) -91.47%
Revenue Per Employee n/a
Profits Per Employee -$947,583
Employee Count 60
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -59.72% in the last 52 weeks. The beta is 1.81, so Passage Bio's price volatility has been higher than the market average.

Beta (5Y) 1.81
52-Week Price Change -59.72%
50-Day Moving Average 7.18
200-Day Moving Average 9.68
Relative Strength Index (RSI) 50.25
Average Volume (20 Days) 85,913

Short Selling Information

The latest short interest is 91,168, so 2.92% of the outstanding shares have been sold short.

Short Interest 91,168
Short Previous Month 108,282
Short % of Shares Out 2.92%
Short % of Float 3.25%
Short Ratio (days to cover) 0.96

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -54.33M
Pretax Income -76.57M
Net Income -56.86M
EBITDA -52.49M
EBIT -54.33M
Earnings Per Share (EPS) -$18.35
Full Income Statement

Balance Sheet

The company has $57.63 million in cash and $24.73 million in debt, giving a net cash position of $32.90 million or $10.54 per share.

Cash & Cash Equivalents 57.63M
Total Debt 24.73M
Net Cash 32.90M
Net Cash Per Share $10.54
Equity (Book Value) 38.26M
Book Value Per Share 12.07
Working Capital 40.51M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$36.07 million and capital expenditures -$34,000, giving a free cash flow of -$36.10 million.

Operating Cash Flow -36.07M
Capital Expenditures -34,000
Free Cash Flow -36.10M
FCF Per Share -$11.57
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Passage Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.82%
Shareholder Yield -7.82%
Earnings Yield -308.83%
FCF Yield -196.10%

Analyst Forecast

The average price target for Passage Bio is $140.00, which is 2,094.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target $140.00
Price Target Difference 2,094.36%
Analyst Consensus Strong Buy
Analyst Count 3
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on July 14, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date Jul 14, 2025
Split Type Reverse
Split Ratio 1:20

Scores

Altman Z-Score n/a
Piotroski F-Score 1